TNFRSF18 and neoplasm: Despite this, in the 4T1 tumor the increased tumor infiltration by effector T cells did not set the stage for response to anti-PD1 or other antibodies targeting the T cell immunomodulatory receptors GITR, OX40, and LAG3.